Picture of Castle Biosciences logo

CSTL — Castle Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Castle Biosciences Inc reports results for the quarter ended in December - Earnings Summary

* Castle Biosciences Inc  CSTL.OQ  reported a quarterly
adjusted
loss of 10 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -78 cents.  The mean expectation of
nine analysts for the quarter was for a loss of 54 cents per
share. Wall Street expected results to range from -95 cents
to -17 cents per share.
    * Revenue rose 72.5% to $66.12 million from a year ago;
analysts
expected $56.28 million. 
    * Castle Biosciences Inc's reported EPS for the quarter was
a loss
of 10 cents​.
    * The company reported a quarterly loss of $2.58 million.
    * Castle Biosciences Inc shares had risen by 16.3% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 20.1%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "strong buy"

Wall Street's median 12-month price target for Castle
Biosciences Inc is $32.00 
This summary was machine generated from LSEG data February 29 at
12:04 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.54          -0.10          Beat
 Sep. 30 2023      -0.76          -0.26          Beat
 Jun. 30 2023      -0.91          -0.70          Beat
 Mar. 31 2023      -0.89          -1.10          Missed

Recent news on Castle Biosciences

See all news